These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30263005)

  • 1. Butein suppresses hepatocellular carcinoma growth via modulating Aurora B kinase activity.
    Zhou Y; Li M; Yu X; Liu T; Li T; Zhou L; Liu W; Li W; Gao F
    Int J Biol Sci; 2018; 14(11):1521-1534. PubMed ID: 30263005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo.
    Rajendran P; Ong TH; Chen L; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Sharma A; Kumar AP; Hui KM; Sethi G
    Clin Cancer Res; 2011 Mar; 17(6):1425-39. PubMed ID: 21131551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butein Inhibited In Vitro Hexokinase-2-Mediated Tumor Glycolysis in Hepatocellular Carcinoma by Blocking Epidermal Growth Factor Receptor (EGFR).
    Liao W; Liu J; Zhang D; Huang W; Chen R
    Med Sci Monit; 2018 May; 24():3283-3292. PubMed ID: 29777095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Aurora B kinase with Tanshinone IIA suppresses tumor growth and overcomes radioresistance.
    Li M; Liu H; Zhao Q; Han S; Zhou L; Liu W; Li W; Gao F
    Cell Death Dis; 2021 Feb; 12(2):152. PubMed ID: 33542222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.
    Ding J; Wen W; Xiang D; Yin P; Liu Y; Liu C; He G; Cheng Z; Yin J; Sheng C; Zhang W; Nan F; Ye W; Zhang X; Wang H
    Oncotarget; 2015 May; 6(13):11627-39. PubMed ID: 25890498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma.
    Aihara A; Tanaka S; Yasen M; Matsumura S; Mitsunori Y; Murakata A; Noguchi N; Kudo A; Nakamura N; Ito K; Arii S
    J Hepatol; 2010 Jan; 52(1):63-71. PubMed ID: 19913935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitization by combining an aurora kinase inhibitor with radiotherapy in hepatocellular carcinoma through cell cycle interruption.
    Lin ZZ; Chou CH; Cheng AL; Liu WL; Chia-Hsien Cheng J
    Int J Cancer; 2014 Jul; 135(2):492-501. PubMed ID: 24375034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extract Derived from
    Huang XF; Chang KF; Lee SC; Sheu GT; Li CY; Weng JC; Hsiao CY; Tsai NM
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33050385
    [No Abstract]   [Full Text] [Related]  

  • 9. Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2.
    Xu D; Jin J; Yu H; Zhao Z; Ma D; Zhang C; Jiang H
    J Exp Clin Cancer Res; 2017 Mar; 36(1):44. PubMed ID: 28320429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel therapeutic combination sequentially targeting aurora B and Bcl-xL in hepatocellular carcinoma.
    Matsunaga H; Tanaka S; Aihara A; Ogawa K; Matsumura S; Ban D; Ochiai T; Irie T; Kudo A; Nakamura N; Arii S; Tanabe M
    Ann Surg Oncol; 2015 Sep; 22(9):3079-86. PubMed ID: 25524010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
    Li T; Dong ZR; Guo ZY; Wang CH; Zhi XT; Zhou JW; Li DK; Chen ZT; Chen ZQ; Hu SY
    Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Aurora A Kinase by Alisertib Induces Autophagy and Cell Cycle Arrest and Increases Chemosensitivity in Human Hepatocellular Carcinoma HepG2 Cells.
    Zhu Q; Yu X; Zhou ZW; Zhou C; Chen XW; Zhou SF
    Curr Cancer Drug Targets; 2017; 17(4):386-401. PubMed ID: 27396604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudolaric acid B exhibits anti-cancer activity on human hepatocellular carcinoma through inhibition of multiple carcinogenic signaling pathways.
    Zhang H; Li JC; Luo H; Zhao L; Zhang ZD; Shen XF
    Phytomedicine; 2019 Jun; 59():152759. PubMed ID: 31004883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Cationic Microbubble Carrying CD/TK Double Suicide Gene and αVβ3 Integrin Antibody in Human Hepatocellular Carcinoma HepG2 Cells.
    Li J; Zhou P; Li L; Zhang Y; Shao Y; Tang L; Tian S
    PLoS One; 2016; 11(7):e0158592. PubMed ID: 27391603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
    Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
    Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyproheptadine, an antihistaminic drug, inhibits proliferation of hepatocellular carcinoma cells by blocking cell cycle progression through the activation of P38 MAP kinase.
    Feng YM; Feng CW; Chen SY; Hsieh HY; Chen YH; Hsu CD
    BMC Cancer; 2015 Mar; 15():134. PubMed ID: 25886177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Aurora/vascular endothelial growth factor receptor dual kinase inhibitor as treatment for hepatocellular carcinoma.
    Nakao K; Tanaka S; Miura T; Sato K; Matsumura S; Aihara A; Mitsunori Y; Ban D; Ochiai T; Kudo A; Arii S; Tanabe M
    Cancer Sci; 2015 Aug; 106(8):1016-22. PubMed ID: 26011703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRD-22, a novel dual dithiocarbamatic acid ester, inhibits Aurora-A kinase and induces apoptosis and cell cycle arrest in HepG2 cells.
    Wang H; Li R; Li L; Ge Z; Zhou R; Li R
    Biochem Biophys Res Commun; 2015 Feb; 458(1):201-7. PubMed ID: 25645017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting high Aurora kinases expression as an innovative therapy for hepatocellular carcinoma.
    Liu F; Wang G; Wang X; Che Z; Dong W; Guo X; Wang Z; Chen P; Hou D; Zhang Q; Zhang W; Pan Y; Yang D; Liu H
    Oncotarget; 2017 Apr; 8(17):27953-27965. PubMed ID: 28427193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.